发明名称 |
Compositions and methods for the treatment of degenerative retinal conditions |
摘要 |
The present invention is directed to compositions and methods for the treatment of degenerative retinal conditions. According to a general aspect, the present invention is directed to inflammatory mediators, preferably components or substrates of the NLRP3-inflammasome, for use in the treatment of degenerative retinal conditions involving drusen and anaphylatoxin-induced choroidal- neovascularisation. The invention is also directed to a method for the treatment of degenerative retinal conditions involving drusen and anaphylatoxin-induced choroidal-neovascularisation and to recombinant vectors and recombinant proteins for use in such methods. The present invention also provides a method for determining the risk of developing or monitoring the progression of diseases involving drusen and anaphylatoxin-induced choroidal neo-vascularisation. |
申请公布号 |
AU2012314330(A1) |
申请公布日期 |
2014.04.17 |
申请号 |
AU20120314330 |
申请日期 |
2012.10.01 |
申请人 |
THE PROVOST, FELLOWS |
发明人 |
CAMPBELL, MATTHEW;HUMPHRIES, PETER;HUMPHRIES, MARIAN;KIANG, ANNA-SOPHIA;DOYLE, SARAH;O'NEILL, LUKE |
分类号 |
A61K38/20;A61P27/02 |
主分类号 |
A61K38/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|